GlassScriptPhysician profile
William Gert Schmidt
NPI 1467455386
$415.98
in general payments reported to CMS, 2019-2025
12 companies · $32.42 in 2025
The $32.42 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $11.75 · 2021: $62.59 · 2022: $85.06 · 2023: $28.73 · 2024: $71.39 · 2025: $32.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $72.42 · Food and Beverage: $60.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $72.42 |
| Food and Beverage | $60.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $87.34 | 2019-2024 | |
| Genentech USA, INC. | $64.99 | 2019 | |
| Aveo Pharmaceuticals, INC. | $60.00 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $55.59 | 2019-2021 | |
| Pharmacyclics LLC, An Abbvie Company | $47.82 | 2022 | |
| Gilead Sciences, INC. | $24.34 | 2021-2025 | Trodelvy |
| Tg Therapeutics, INC. | $24.00 | 2022 | |
| Jazz Pharmaceuticals INC. | $20.63 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $18.23 | 2019 | |
| Pfizer INC. | $13.04 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.